Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

9.1%

1 terminated out of 11 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

89% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (3)
P 2 (5)
P 3 (1)
P 4 (1)

Trial Status

Completed8
Not Yet Recruiting1
Terminated1
Recruiting1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (11)

Showing 11 of 11 trials
Showing all 11 trials

Research Network

Activity Timeline